Sex differences in clinical features, utilization of oral anticoagulant agents, and 1-year outcome in Middle Eastern patients with atrial fibrillation

References

• Staerk L, Sherer JA, Ko D, et al. Atrial fibrillation. Circ Res. 2017;120(9):1501–1517. doi:10.1161/CIRCRESAHA.117.309732.
   PubMed Web of Science ®Google Scholar
• Nesheiwat Z, Goyal A, Jagtap M. Atrial fibrillation. StatPearls. [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK526072/
   Google Scholar
• Westerman S, Wenger N. Gender differences in atrial fibrillation: a review of epidemiology, management, and outcomes. Curr Cardiol Rev. 2019;15(2):136–144. doi:10.2174/1573403X15666181205110624.
   PubMed Web of Science ®Google Scholar
• Tamirisa KP, Calvert P, Dye C, et al. Sex differences in atrial fibrillation. Curr Cardiol Rep. 2023;25(9):1075–1082. doi:10.1007/s11886-023-01927-1.
   PubMedGoogle Scholar
• Andrade JG, Deyell MW, Lee AYK, et al. Sex differences in atrial fibrillation. Can J Cardiol. 2018;34(4):429–436. doi:10.1016/j.cjca.2017.11.022.
   PubMed Web of Science ®Google Scholar
• Volgman AS, Benjamin EJ, Curtis AB, et al. Women and atrial fibrillation. J Cardiovasc Electrophysiol. 2021;32(10):2793–2807. doi:10.1111/jce.14838.
   PubMed Web of Science ®Google Scholar
• Emdin CA, Wong CX, Hsiao AJ, et al. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. BMJ. 2016;532:h7013. doi:10.1136/bmj.h7013.
   PubMed Web of Science ®Google Scholar
• Dagres N, Nieuwlaat R, Vardas PE, et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol. 2007;49(5):572–577. doi:10.1016/j.jacc.2006.10.047.
   PubMed Web of Science ®Google Scholar
• Hagens VE, Ranchor AV, Van Sonderen E, et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol. 2004;43(2):241–247. doi:10.1016/j.jacc.2003.08.037.
   PubMed Web of Science ®Google Scholar
• Rienstra M, Van Veldhuisen DJ, Hagens VE, et al. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol. 2005;46(7):1298–1306. doi:10.1016/j.jacc.2005.05.078.
   PubMed Web of Science ®Google Scholar
• Lip GYH, Laroche C, Boriani G, et al. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. Europace. 2015;17(1):24–31. doi:10.1093/europace/euu155.
   PubMed Web of Science ®Google Scholar
• Friberg J, Scharling H, Gadsbøll N, et al. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (the Copenhagen City Heart Study). Am J Cardiol. 2004;94(7):889–894. doi:10.1016/j.amjcard.2004.06.023.
   PubMed Web of Science ®Google Scholar
• Friberg L, Benson L, Rosenqvist M, et al. Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study. BMJ. 2012;344(may30 3):e3522–e3522. doi:10.1136/bmj.e3522.
   PubMedGoogle Scholar
• Mikkelsen AP, Lindhardsen J, Lip GYH, et al. Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study. J Thromb Haemost. 2012;10(9):1745–1751. doi:10.1111/j.1538-7836.2012.04853.x.
   PubMed Web of Science ®Google Scholar
• Buhari H, Fang J, Han L, et al. Stroke risk in women with atrial fibrillation. Eur Heart J. 2023;45(2):ehad508. doi:10.1093/eurheartj/ehad508.
   Web of Science ®Google Scholar
• Nielsen PB, Skjøth F, Overvad TF, et al. Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrillation. Circulation. 2018;137(8):832–840. doi:10.1161/CIRCULATIONAHA.117.029081.
   PubMed Web of Science ®Google Scholar
• Abdel-Qadir H, Singh SM, Pang A, et al. Evaluation of the risk of stroke without anticoagulation therapy in men and women with atrial fibrillation aged 66 to 74 years without other CHA2DS2-VASc factors. JAMA Cardiol. 2021;6(8):918–925. doi:10.1001/jamacardio.2021.1232.
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Calkins H, et al. AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74(1):104–132. 2019 doi:10.1016/j.jacc.2019.01.011.
   PubMed Web of Science ®Google Scholar
• Shehab A, Zubaid M, Bhagavathula AS, et al. Sex differences in management and outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events (Gulf SAFE). PLoS One. 2017;12(5):e0175405. doi:10.1371/journal.pone.0175405.
   PubMed Web of Science ®Google Scholar
• Hammoudeh AJ, Khader Y, Kadri N, et al. Adherence to the 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline on the use of oral anticoagulant agents in Middle Eastern patients with atrial fibrillation: the Jordan Atrial Fibrillation (JoFib) Study. Int J Vasc Med. 2021;2021:1–9. doi:10.1155/2021/5515089.
   Web of Science ®Google Scholar
• Wilke T, Groth A, Mueller S, et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace. 2013;15(4):486–493. doi:10.1093/europace/eus333.
   PubMed Web of Science ®Google Scholar
• Magnussen C, Niiranen TJ, Ojeda FM, et al. Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts. Circulation. 2017;136(17):1588–1597. doi:10.1161/CIRCULATIONAHA.117.028981.
   PubMed Web of Science ®Google Scholar
• Ko D, Rahman F, Schnabel RB, et al. Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nat Rev Cardiol. 2016;13(6):321–332. doi:10.1038/nrcardio.2016.45.
   PubMed Web of Science ®Google Scholar
• Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386(9989):154–162. doi:10.1016/S0140-6736(14)61774-8.
   PubMed Web of Science ®Google Scholar
• Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292(20):2471–2477. doi:10.1001/jama.292.20.2471.
   PubMed Web of Science ®Google Scholar
• Potpara TS, Marinkovic JM, Polovina MM, et al. Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study. Int J Cardiol. 2012;161(1):39–44. doi:10.1016/j.ijcard.2011.04.022.
   PubMed Web of Science ®Google Scholar
• Scheuermeyer FX, Mackay M, Christenson J, et al. There are sex differences in the demographics and risk profiles of emergency department (ED) patients with atrial fibrillation and flutter, but no apparent differences in ED management or outcomes. Acad Emerg Med. 2015;22(9):1067–1075. doi:10.1111/acem.12750.
   PubMed Web of Science ®Google Scholar
• Gillis AM. Atrial fibrillation and ventricular arrhythmias. Circulation. 2017;135(6):593–608. doi:10.1161/CIRCULATIONAHA.116.025312.
   PubMed Web of Science ®Google Scholar
• Piccini JP, Simon DN, Steinberg BA, et al. Differences in clinical and functional outcomes of atrial fibrillation in women and men: two-year results from the ORBIT-AF registry. JAMA Cardiol. 2016;1(3):282–291. doi:10.1001/jamacardio.2016.0529.
   PubMed Web of Science ®Google Scholar
• Schnabel RB, Pecen L, Ojeda FM, et al. Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation. Heart. 2017;103(13):1024–1030. doi:10.1136/heartjnl-2016-310406.
   PubMed Web of Science ®Google Scholar
• Lip GYH, Rushton-Smith SK, Goldhaber SZ, et al. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? Circ Cardiovasc Qual Outcomes. 2015;8(2 Suppl 1):S12–S20. doi:10.1161/CIRCOUTCOMES.114.001556.
   PubMed Web of Science ®Google Scholar
• Shantsila E, Wolff A, Lip GYH, et al. Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool. Int J Clin Pract. 2015;69(8):840–845. doi:10.1111/ijcp.12625.
   PubMed Web of Science ®Google Scholar
• Kassim NA, Althouse AD, Qin D, et al. Gender differences in management and clinical outcomes of atrial fibrillation patients. J Cardiol. 2017;69(1):195–200. doi:10.1016/j.jjcc.2016.02.022.
   PubMed Web of Science ®Google Scholar
• Thompson LE, Maddox TM, Lei L, et al. Sex differences in the use of oral anticoagulants for atrial fibrillation: a report from the National Cardiovascular Data Registry (NCDR®) PINNACLE Registry. J Am Heart Assoc. 2017;6(7):e005801. doi:10.1161/JAHA.117.005801.
   PubMed Web of Science ®Google Scholar
• Pancholy SB, Sharma PS, Pancholy DS, et al. Meta-Analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants. Am J Cardiol. 2014;113(3):485–490. doi:10.1016/j.amjcard.2013.10.035.
   PubMed Web of Science ®Google Scholar
• Sullivan RM, Zhang J, Zamba G, et al. Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM). Am J Cardiol. 2012;110(12):1799–1802. doi:10.1016/j.amjcard.2012.08.014.
   PubMed Web of Science ®Google Scholar
• Washam JB, Stevens SR, Lokhnygina Y, et al. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Lancet. 2015;385(9985):2363–2370. doi:10.1016/S0140-6736(14)61836-5.
   PubMed Web of Science ®Google Scholar
• Patel N, Deshmukh A, Thakkar B, et al. Gender, race, and health insurance status in patients undergoing catheter ablation for atrial fibrillation. Am J Cardiol. 2016;117(7):1117–1126. doi:10.1016/j.amjcard.2016.01.040.
   PubMed Web of Science ®Google Scholar
• Bhave PD, Lu X, Girotra S, et al. Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation. Heart Rhythm. 2015;12(7):1406–1412. https://www.sciencedirect.com/science/article/pii/S1547527115003306. doi:10.1016/j.hrthm.2015.03.031.
   PubMed Web of Science ®Google Scholar
• Avgil Tsadok M, Gagnon J, Joza J, et al. Temporal trends and sex differences in pulmonary vein isolation for patients with atrial fibrillation. Heart Rhythm. 2015;12(9):1979–1986. doi:10.1016/j.hrthm.2015.06.029.
   PubMed Web of Science ®Google Scholar
• Zylla MM, Brachmann J, Lewalter T, et al. Sex-related outcome of atrial fibrillation ablation: insights from the German Ablation Registry. Heart Rhythm. 2016;13(9):1837–1844. doi:10.1016/j.hrthm.2016.06.005.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Wolf PA, D’Agostino RB, et al. Impact of atrial fibrillation on the risk of death. Circulation. 1998;98(10):946–952. doi:10.1161/01.CIR.98.10.946.
   PubMed Web of Science ®Google Scholar
• Marijon E, Le Heuzey J-Y, Connolly S, et al. Causes of death and influencing factors in patients with atrial fibrillation. Circulation. 2013;128(20):2192–2201. doi:10.1161/CIRCULATIONAHA.112.000491.
   PubMed Web of Science ®Google Scholar
• Marinigh R, Lip GYH, Fiotti N, et al. Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis. J Am Coll Cardiol. 2010;56(11):827–837. doi:10.1016/j.jacc.2010.05.028.
   PubMed Web of Science ®Google Scholar
• Wändell PE, Carlsson AC, Sundquist J, et al. Pharmacotherapy and mortality in atrial fibrillation—a cohort of men and women 75 years or older in Sweden. Age Ageing. 2015;44(2):232–238. doi:10.1093/ageing/afu153.
   PubMed Web of Science ®Google Scholar
• Abdel-Qadir H, Akioyamen LE, Fang J, et al. Association of Neighborhood-Level material deprivation with atrial fibrillation care in a single-payer health care system: a population-based cohort study. Circulation. 2022;146(3):159–171. doi:10.1161/CIRCULATIONAHA.122.058949.
   PubMed Web of Science ®Google Scholar
• Hagengaard L, Andersen MP, Polcwiartek C, et al. Socioeconomic differences in outcomes after hospital admission for atrial fibrillation or flutter. Eur Heart J Qual Care Clin Outcomes. 2021;7(3):295–303. doi:10.1093/ehjqcco/qcz053.
   PubMed Web of Science ®Google Scholar
• Azenkot T, Schwarz EB. Special considerations for women of reproductive age on anticoagulation. J Gen Intern Med. 2022;37(11):2803–2810. doi:10.1007/s11606-022-07528-y.
   PubMed Web of Science ®Google Scholar
• Evers-Dörpfeld S, Aeschbacher S, Hennings E, et al. Sex-specific differences in adverse outcome events among patients with atrial fibrillation. Heart. 2022;108(18):1445–1451. doi:10.1136/heartjnl-2021-320122.
   PubMed Web of Science ®Google Scholar